Armata Pharmaceuticals Inc (ARMP)
2.36
+0.05
(+2.16%)
USD |
NYAM |
Nov 01, 16:00
Armata Pharmaceuticals Max Drawdown (5Y): 99.87% for Sept. 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2024 | 99.87% |
| August 31, 2024 | 99.87% |
| July 31, 2024 | 99.87% |
| June 30, 2024 | 99.87% |
| May 31, 2024 | 99.87% |
| April 30, 2024 | 99.87% |
| March 31, 2024 | 99.87% |
| February 29, 2024 | 99.87% |
| January 31, 2024 | 99.89% |
| December 31, 2023 | 99.91% |
| November 30, 2023 | 99.92% |
| October 31, 2023 | 99.93% |
| September 30, 2023 | 99.94% |
| August 31, 2023 | 99.94% |
| July 31, 2023 | 99.94% |
| June 30, 2023 | 99.94% |
| May 31, 2023 | 99.94% |
| April 30, 2023 | 99.94% |
| March 31, 2023 | 99.94% |
| February 28, 2023 | 99.94% |
| January 31, 2023 | 99.94% |
| December 31, 2022 | 99.94% |
| November 30, 2022 | 99.94% |
| October 31, 2022 | 99.94% |
| September 30, 2022 | 99.94% |
| Date | Value |
|---|---|
| August 31, 2022 | 99.94% |
| July 31, 2022 | 99.94% |
| June 30, 2022 | 99.94% |
| May 31, 2022 | 99.94% |
| April 30, 2022 | 99.94% |
| March 31, 2022 | 99.94% |
| February 28, 2022 | 99.94% |
| January 31, 2022 | 99.94% |
| December 31, 2021 | 99.94% |
| November 30, 2021 | 99.94% |
| October 31, 2021 | 99.94% |
| September 30, 2021 | 99.94% |
| August 31, 2021 | 99.94% |
| July 31, 2021 | 99.94% |
| June 30, 2021 | 99.94% |
| May 31, 2021 | 99.94% |
| April 30, 2021 | 99.94% |
| March 31, 2021 | 99.94% |
| February 28, 2021 | 99.94% |
| January 31, 2021 | 99.94% |
| December 31, 2020 | 99.94% |
| November 30, 2020 | 99.94% |
| October 31, 2020 | 99.94% |
| September 30, 2020 | 99.94% |
| August 31, 2020 | 99.94% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
99.87%
Minimum
Feb 2024
99.94%
Maximum
Nov 2019
99.93%
Average
99.94%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| AIM ImmunoTech Inc | 99.61% |
| Perspective Therapeutics Inc | 91.70% |
| Protalix BioTherapeutics Inc | 94.35% |
| Electromed Inc | 55.84% |
| Xtant Medical Holdings Inc | 98.66% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -21.72 |
| Beta (5Y) | 0.7968 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 129.6% |
| Historical Sharpe Ratio (5Y) | -0.0836 |
| Historical Sortino (5Y) | -0.2815 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 31.97% |